Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BAFNA PHARM. Plunges 5%; BSE HEALTHCARE Index Up 0.4%
Tue, 27 Aug 14:41

BAFNA PHARM. Plunges 5%; BSE HEALTHCARE Index Up 0.4%Image source: KanawatTH/www.istockphoto.com

BAFNA PHARM. share price has plunged 5% and is presently trading at Rs 82.0.

Meanwhile, the BSE HEALTHCARE index is at 42,350.2 (up 0.4%).

Among the top losers in the BSE HEALTHCARE index today are SYNGENE INTERNATIONAL (down 2.9%) and GRANULES INDIA (down 2.2%).

Jubilant Pharmova (up 3.6%) and CAPLIN POINT (up 3.6%) are among the top gainers today.

Over the last one year, BAFNA PHARM. has moved down from Rs 110.1 to Rs 82.0, registering a loss of Rs 28.1 (down 25.5%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,099.5 to 42,350.2, registering a gain of 50.7% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 126.8%), Glenmark Pharma (up 125.4%) and SUVEN PHARMACEUTICALS (up 104.2%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 81,841.8 (up 0.2%).

The top gainers among the BSE Sensex today are Maruti Suzuki (up 2.1%) and L&T (up 1.9%). The most traded stocks in the BSE Sensex are ICICI Bank and Tata Steel.

In the meantime, NSE Nifty is at 25,040.5 (up 0.1%). Shriram Transport and SBI LIFE INSURANCE are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,433.3 to 81,841.8, registering a gain of 16,408.5 points (up 25.1%).

BAFNA PHARM. Financial Update...

BAFNA PHARM. net profit fell 111.4% YoY to Rs -7 million for the quarter ended June 2024, compared to a profit of Rs 64 million a year ago. Net sales declined 20.6% to Rs 333 million during the period as against Rs 419 million in April-June 2023.

For the year ended March 2023, BAFNA PHARM. reported 117.3% increase in net profit to Rs 113 million compared to net profit of Rs 52 million during FY22. Revenue of the company grew 35.5% to Rs 1,153 million during FY23.

The current Price to earnings ratio of BAFNA PHARM., based on rolling 12 month earnings, stands at 708.1.


Equitymaster requests your view! Post a comment on "BAFNA PHARM. Plunges 5%; BSE HEALTHCARE Index Up 0.4%". Click here!